Amaero Inc.
Amaero Inc., a U.S.-based producer of refractory and titanium alloy metal powders for additive manufacturing and PM-HIP components, filed Amendment No. 1 to its S-1 registration statement for an initial public offering on Nasdaq under the symbol "AMRO." The company is offering 7,456,500 shares of common stock, with underwriters Stifel and Baird granted a 1,118,475-share overallotment option. Amaero's CDIs currently trade on the ASX at A$0.245 per CDI (equivalent to approximately $7.06 per share), and the IPO price will be determined through negotiations with underwriters.
- Amaero is offering 7,456,500 shares of common stock with an underwriter option for an additional 1,118,475 shares.
- The company's CDIs trade on the ASX under symbol '3DA' at A$0.245 per CDI, implying approximately $7.06 per share.
- Amaero produces refractory and titanium alloy powders for hypersonic weapons, satellite propulsion, and aerospace applications.
- The company completed a three-year capital investment program of over $45.0 million and is transitioning to revenue growth.
- Amaero redomiciled from Australia to Delaware on June 22, 2026, with Amaero Ltd becoming a wholly owned subsidiary.
Price data unavailable.
Amaero operates the only EIGA Premium atomizer in the U.S. and supplies critical materials for hypersonic weapons and Navy submarine components — a rare defense-industrial pure play accessing U.S.公共市场
Amaero positions itself at the intersection of defense-driven reshoring and additive manufacturing, citing the 2026 NDAA, Trump administration initiatives, and Navy submarine industrial base bottlenecks as tailwinds for domestic powder and PM-HIP production.
The offering price will be negotiated with underwriters based on ASX CDI trading prices, creating valuation uncertainty. ASX listing rules limit the amount of common stock the company can issue without stockholder approval, potentially constraining future capital raises.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.